Determining the Effects of Temozolomide Followed by Nivolumab in Patients With Colorectal Cancer
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03879811 |
|
Recruitment Status :
Withdrawn
(No accrual)
First Posted : March 19, 2019
Last Update Posted : December 12, 2019
|
Sponsor:
Memorial Sloan Kettering Cancer Center
Collaborator:
Bristol-Myers Squibb
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
| Recruitment Status : | Withdrawn |
|---|---|
| Estimated Primary Completion Date : | March 2021 |
| Estimated Study Completion Date : | March 2021 |